What is Eden Labs?
With a legacy spanning over 25 years, Eden Labs operates at the intersection of advanced engineering and botanical science. The company specializes in the design and deployment of high-performance extraction equipment, most notably its proprietary Supercritical CO2 FX2 systems and Coldfinger distillation technology. These solutions are engineered to maximize yield and operational efficiency for clients navigating the complex regulatory and technical requirements of the cannabis and botanical industries. Beyond hardware manufacturing, Eden Labs provides comprehensive support services, including product development, research, and toll processing, effectively positioning itself as a full-service partner for enterprises seeking to scale their production capabilities through precision-engineered technology.
How much funding has Eden Labs raised?
Eden Labs has raised a total of $323K across 2 funding rounds:
Debt
$150K
Debt
$173K
Debt (2020): $150K with participation from PPP
Debt (2021): $173K led by PPP
Key Investors in Eden Labs
PPP
Public-Private Partnership
What's next for Eden Labs?
The infusion of capital from this late-stage financing round provides Eden Labs with the necessary liquidity to accelerate its research and development initiatives and expand its footprint in emerging botanical markets. As the industry shifts toward higher standards of purity and efficiency, the company is well-positioned to capitalize on the increasing demand for sophisticated extraction infrastructure. Strategic priorities likely include the refinement of its existing technology suite to meet evolving global standards and the potential scaling of its toll processing services to accommodate a broader client base. By maintaining its focus on technological innovation and client-centric service, Eden Labs is poised to maintain its leadership status while navigating the complexities of the rapidly maturing botanical extraction sector.
See full Eden Labs company page
